Found 19 matching trials
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) PHASE3 The purpose of this study is to evaluate the safety and efficacy of risanki...
Show More Location
Pinnacle Research Group /ID# 167953
Learn More & Join Trial
Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation PHASE3 The purpose of this study is to assess the safety and efficacy of risankizu...
Show More Location
GBUZ Clinical Dermatovenerology Dispensary of MoH of Krasnodar region /ID# 201713
Learn More & Join Trial
BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE2 This is a randomized double blind, double dummy, placebo controlled, parall...
Show More Location
Multiple Locations
Learn More & Join Trial
BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE3 This is a randomized double blind, double dummy, placebo and active compara...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. PHASE3 Crohn's disease (CD) is a long-lasting disease that causes severe inflammat...
Show More Status
Active Not Recruiting
Location
Gi Alliance - Arizona Digestive Health - Sun City /ID# 268178
Learn More & Join Trial
Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease. PHASE2 This study is a proof of concept, multi-center, randomized, double-blind, p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa PHASE2 The primary objective of this study is to assess the safety and efficacy of...
Show More Location
Burke Pharmaceutical Research /ID# 211671
Learn More & Join Trial
A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis PHASE3 The primary objective of this study was to evaluate the safety and efficacy...
Show More Location
Total Skin and Beauty Derm Ctr /ID# 210366
Learn More & Join Trial
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease PHASE3 The study consists of 4 sub-studies, as follows:
* Sub-study 1 (Randomized...
Show More Status
Active Not Recruiting
Location
Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884
Learn More & Join Trial
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE3 The purpose of this study is to assess the safety and efficacy of BI 655066...
Show More Location
Multiple Locations
Learn More & Join Trial